Literature DB >> 19921133

[Allergen-specific Immunotherapy for children and adolescents - a review on available products in Austria].

Zsolt Szépfalusi1, Waltraud Emminger, Franz Eitelberger, Manfred Götz, Andrea Grillenberger, Elisabeth Horak, Isidor Huttegger, Dieter Koller, Helmut Litscher, Rudolf Schmitzberger, Eva-Maria Varga, Josef Riedler.   

Abstract

A pediatric consensus report on allergen-specific immunotherapy for children and adolescents is presented for Austria. Products on the market in Austria are presented and categorised according to studies performed on the target population of children and adolescents, their effectiveness and indication. In general, more clinical studies on children and adolescents are mandatory for most of the available allergen-specific immunotherapeutics. In addition, the use of allergen-specific immunotherapy in general should be promoted as the exclusive treatment with long-lasting effects in type I allergies in particular in children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19921133     DOI: 10.1007/s00508-009-1258-8

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  134 in total

1.  Symposium on the definition and management of anaphylaxis: summary report.

Authors:  Hugh A Sampson; Anne Muñoz-Furlong; S Allan Bock; Cara Schmitt; Robert Bass; Badrul A Chowdhury; Wyatt W Decker; Terence J Furlong; Stephen J Galli; David B Golden; Rebecca S Gruchalla; Allen D Harlor; David L Hepner; Marilyn Howarth; Allen P Kaplan; Jerrold H Levy; Lawrence M Lewis; Phillip L Lieberman; Dean D Metcalfe; Ramon Murphy; Susan M Pollart; Richard S Pumphrey; Lanny J Rosenwasser; F Estelle Simons; Joseph P Wood; Carlos A Camargo
Journal:  J Allergy Clin Immunol       Date:  2005-03       Impact factor: 10.793

Review 2.  Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology.

Authors:  J Bousquet; R Lockey; H J Malling; E Alvarez-Cuesta; G W Canonica; M D Chapman; P J Creticos; J M Dayer; S R Durham; P Demoly; R J Goldstein; T Ishikawa; K Ito; D Kraft; P H Lambert; H Løwenstein; U Müller; P S Norman; R E Reisman; R Valenta; E Valovirta; H Yssel
Journal:  Ann Allergy Asthma Immunol       Date:  1998-11       Impact factor: 6.347

3.  Long-term efficacy of preseasonal grass pollen immunotherapy in children.

Authors:  P A Eng; M Reinhold; H P E Gnehm
Journal:  Allergy       Date:  2002-04       Impact factor: 13.146

4.  Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

Authors:  Christian Möller; Sten Dreborg; Hosne A Ferdousi; Susanne Halken; Arne Høst; Lars Jacobsen; Antti Koivikko; Dieter Y Koller; Bodo Niggemann; Lene A Norberg; Radvan Urbanek; Erkka Valovirta; Ulrich Wahn
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

5.  Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.

Authors:  Martin Penagos; Enrico Compalati; Francesco Tarantini; Rodrigo Baena-Cagnani; Jose Huerta; Giovanni Passalacqua; Giorgio Walter Canonica
Journal:  Ann Allergy Asthma Immunol       Date:  2006-08       Impact factor: 6.347

6.  Bee-venom allergy in children: long-term predictive value of standardized challenge tests.

Authors:  Georg E Schuetze; Johannes Forster; Pia J Hauk; Katrin Friedl; Joachim Kuehr
Journal:  Pediatr Allergy Immunol       Date:  2002-02       Impact factor: 6.377

Review 7.  Mechanisms of allergen-specific immunotherapy.

Authors:  Mübeccel Akdis; Cezmi A Akdis
Journal:  J Allergy Clin Immunol       Date:  2007-02-26       Impact factor: 10.793

Review 8.  The impact of pollen-related food allergens on pollen allergy.

Authors:  B Bohle
Journal:  Allergy       Date:  2007-01       Impact factor: 13.146

9.  Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.

Authors:  A B Tonnel; A Scherpereel; B Douay; B Mellin; D Leprince; N Goldstein; P Delecluse; C Andre
Journal:  Allergy       Date:  2004-05       Impact factor: 13.146

10.  Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy.

Authors:  G Hedlin; H Heilborn; G Lilja; K Norrlind; K O Pegelow; C Schou; H Løwenstein
Journal:  J Allergy Clin Immunol       Date:  1995-12       Impact factor: 10.793

View more
  1 in total

Review 1.  Clinical practice: Allergen-specific immunotherapy in children: facts and FAQs.

Authors:  Zsolt Szépfalusi; Saskia Gruber; Thomas Eiwegger; Eleonora Dehlink
Journal:  Eur J Pediatr       Date:  2010-12-10       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.